Gene regulatory control of myocardial energy metabolism predicts postoperative cardiac function in patients undergoing off-pump coronary artery bypass graft surgery: inhalational versus intravenous anesthetics
- PMID: 17325502
- DOI: 10.1097/00000542-200703000-00008
Gene regulatory control of myocardial energy metabolism predicts postoperative cardiac function in patients undergoing off-pump coronary artery bypass graft surgery: inhalational versus intravenous anesthetics
Abstract
Background: Anesthetic gases modulate gene expression and provide organ protection. This study aimed at identifying myocardial transcriptional phenotypes to predict cardiovascular biomarkers and function in patients undergoing off-pump coronary artery bypass graft surgery.
Methods: In a prospective randomized trial, patients undergoing elective off-pump coronary artery bypass graft surgery were allocated to receive either the anesthetic gas sevoflurane (n = 10) or the intravenous anesthetic propofol (n = 10). Blood samples were collected perioperatively to determine cardiac troponin T, N-terminal pro-brain natriuretic peptide, and pregnancy-associated plasma protein A. Cardiac function was measured with transesophageal echocardiography and pulmonary artery thermodilution. Atrial biopsies were collected at the beginning and end of bypass surgery to determine gene expression profiles.
Results: N-terminal pro-brain natriuretic peptide and pregnancy-associated plasma protein A blood levels were decreased with sevoflurane treatment. Echocardiography showed preserved postoperative cardiac function in sevoflurane patients, which paralleled higher cardiac index measurements. N-terminal pro-brain natriuretic peptide release was predicted by sevoflurane-induced transcriptional reduction in fatty acid oxidation, whereas changes in cardiac index were predicted by preoperative gene activity of the peroxisome proliferator-activated receptor gamma coactivator-1alpha pathway. Sevoflurane-mediated attenuation of transcripts involved in DNA-damage signaling and activation of the granulocyte colony-stimulating factor survival pathway predicted improved postoperative cardiac index and diastolic heart function, respectively.
Conclusions: Anesthetic-induced and constitutive gene regulatory control of myocardial substrate metabolism predicts postoperative cardiac function in patients undergoing off-pump coronary artery bypass graft surgery. The authors' analysis further points to novel cardiac survival pathways as potential therapeutic targets in perioperative cardioprotection.
Comment in
-
"A razor may be sharper than an ax, but it cannot cut wood".Anesthesiology. 2007 Mar;106(3):420-2. doi: 10.1097/00000542-200703000-00004. Anesthesiology. 2007. PMID: 17325498 No abstract available.
Similar articles
-
Sevoflurane Versus Total Intravenous Anesthesia for Isolated Coronary Artery Bypass Surgery With Cardiopulmonary Bypass: A Randomized Trial.J Cardiothorac Vasc Anesth. 2016 Oct;30(5):1221-7. doi: 10.1053/j.jvca.2016.02.030. Epub 2016 Mar 3. J Cardiothorac Vasc Anesth. 2016. PMID: 27431595 Clinical Trial.
-
Propofol Provides More Effective Protection for Circulating Lymphocytes Than Sevoflurane in Patients Undergoing Off-Pump Coronary Artery Bypass Graft Surgery.J Cardiothorac Vasc Anesth. 2015 Oct;29(5):1172-9. doi: 10.1053/j.jvca.2015.01.008. Epub 2015 Feb 19. J Cardiothorac Vasc Anesth. 2015. PMID: 26205644 Clinical Trial.
-
Preconditioning by sevoflurane decreases biochemical markers for myocardial and renal dysfunction in coronary artery bypass graft surgery: a double-blinded, placebo-controlled, multicenter study.Anesthesiology. 2003 Jun;98(6):1315-27. doi: 10.1097/00000542-200306000-00004. Anesthesiology. 2003. PMID: 12766638 Clinical Trial.
-
Sevoflurane in intraoperative and postoperative cardiac surgery patients. Our experience in intensive care unit with sevoflurane sedation.Curr Pharm Des. 2013;19(22):3996-4002. doi: 10.2174/1381612811319220008. Curr Pharm Des. 2013. PMID: 23228318 Review.
-
Volatile Anesthetics versus Propofol for Cardiac Surgery with Cardiopulmonary Bypass: Meta-analysis of Randomized Trials.Anesthesiology. 2020 Jun;132(6):1429-1446. doi: 10.1097/ALN.0000000000003236. Anesthesiology. 2020. PMID: 32205551
Cited by
-
NF-kB signaling in cardiomyocytes is inhibited by sevoflurane and promoted by propofol.FEBS Open Bio. 2020 Feb;10(2):259-267. doi: 10.1002/2211-5463.12783. Epub 2020 Jan 15. FEBS Open Bio. 2020. PMID: 31898867 Free PMC article.
-
Meta-analysis of the cardioprotective effect of sevoflurane versus propofol during cardiac surgery.BMC Anesthesiol. 2015 Sep 24;15:128. doi: 10.1186/s12871-015-0107-8. BMC Anesthesiol. 2015. PMID: 26404434 Free PMC article.
-
Diabetes, perioperative ischaemia and volatile anaesthetics: consequences of derangements in myocardial substrate metabolism.Cardiovasc Diabetol. 2013 Mar 4;12:42. doi: 10.1186/1475-2840-12-42. Cardiovasc Diabetol. 2013. PMID: 23452502 Free PMC article. Review.
-
A brief history of M. C. Schaub's legacies: a life dedicated to heart and muscle research : In memoriam Marcus C. Schaub (1936-2018).J Muscle Res Cell Motil. 2018 Aug;39(3-4):61-63. doi: 10.1007/s10974-019-09502-4. J Muscle Res Cell Motil. 2018. PMID: 30810926 No abstract available.
-
Personalized analysis of pathway aberrance induced by sevoflurane and propofol.Mol Med Rep. 2017 Oct;16(4):5312-5320. doi: 10.3892/mmr.2017.7305. Epub 2017 Aug 21. Mol Med Rep. 2017. PMID: 28849088 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases